These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 6373699)
1. Structure-activity relations of 5,6-cis carbapenem antibiotics and role of factors determining susceptibility of Escherichia coli to beta-lactam antibiotics. Nozaki Y; Harada S; Kitano K; Imada A J Antibiot (Tokyo); 1984 Mar; 37(3):218-26. PubMed ID: 6373699 [TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay. Okamoto K; Gotoh N; Nishino T Antimicrob Agents Chemother; 2001 Jul; 45(7):1964-71. PubMed ID: 11408209 [TBL] [Abstract][Full Text] [Related]
3. Mutations affecting the resistance of Escherichia coli K-12 to beta-lactam antibiotics. Hrebenda J; Heleszko H J Antimicrob Chemother; 1985 Aug; 16(2):149-56. PubMed ID: 3905746 [TBL] [Abstract][Full Text] [Related]
4. Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment. Nikaido H; Normark S Mol Microbiol; 1987 Jul; 1(1):29-36. PubMed ID: 3330755 [TBL] [Abstract][Full Text] [Related]
5. The Importance of Porins and β-Lactamase in Outer Membrane Vesicles on the Hydrolysis of β-Lactam Antibiotics. Kim SW; Lee JS; Park SB; Lee AR; Jung JW; Chun JH; Lazarte JMS; Kim J; Seo JS; Kim JH; Song JW; Ha MW; Thompson KD; Lee CR; Jung M; Jung TS Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316670 [TBL] [Abstract][Full Text] [Related]
6. Effect of interaction between outer membrane permeability and beta-lactamase production on resistance to beta-lactam agents in gram-negative bacteria. Sawai T; Yamaguchi A; Hiruma R Rev Infect Dis; 1988; 10(4):761-4. PubMed ID: 3055174 [TBL] [Abstract][Full Text] [Related]
7. beta-Lactamases and beta-lactam resistance in Escherichia coli. Jacoby GA; Sutton L Antimicrob Agents Chemother; 1985 Nov; 28(5):703-5. PubMed ID: 3911882 [TBL] [Abstract][Full Text] [Related]
8. Susceptibility profile of Gram-negative bacteremic isolates to beta lactam-beta lactamase inhibitor agents in comparison to other antibiotics. Abdul Ghafur K; Vidyalakshmi PR; Jayalakshmi VA; Poojary I Indian J Cancer; 2014; 51(4):450-2. PubMed ID: 26842157 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of new 2-substituted penem antibiotics. Fontana R; Altamura M; Arcamone F; Cornaglia G; Morandotti G; Sperning R; Valisena S; Satta G J Antibiot (Tokyo); 1995 Dec; 48(12):1488-93. PubMed ID: 8557607 [TBL] [Abstract][Full Text] [Related]
10. Potent activity of meropenem against Escherichia coli arising from its simultaneous binding to penicillin-binding proteins 2 and 3. Sumita Y; Fukasawa M J Antimicrob Chemother; 1995 Jul; 36(1):53-64. PubMed ID: 8537284 [TBL] [Abstract][Full Text] [Related]
11. A novel method for evaluating the outer membrane permeability to beta-lactamase-stable beta-lactam antibiotics. Kojo H; Shigi Y; Nishida M J Antibiot (Tokyo); 1980 Mar; 33(3):310-6. PubMed ID: 6991466 [TBL] [Abstract][Full Text] [Related]
12. Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibiotics. Bradford PA; Sanders CC Antimicrob Agents Chemother; 1995 Feb; 39(2):308-13. PubMed ID: 7726487 [TBL] [Abstract][Full Text] [Related]
13. Impact of defined cell envelope mutations in Escherichia coli on the in vitro antibacterial activity of avibactam/β-lactam combinations. McLeod SM; Patey SA; Huband MD; Nichols WW Int J Antimicrob Agents; 2017 Apr; 49(4):437-442. PubMed ID: 28242258 [TBL] [Abstract][Full Text] [Related]
14. Enterobactin-mediated delivery of β-lactam antibiotics enhances antibacterial activity against pathogenic Escherichia coli. Zheng T; Nolan EM J Am Chem Soc; 2014 Jul; 136(27):9677-91. PubMed ID: 24927110 [TBL] [Abstract][Full Text] [Related]
15. beta-Lactamases and susceptibility to beta-lactam antibiotics in Escherichia coli. Wu PJ; Shannon K; Phillips I J Antimicrob Chemother; 1992 Dec; 30(6):868-71. PubMed ID: 1344881 [No Abstract] [Full Text] [Related]
16. Quantitative analysis of beta-lactamase production of multiple resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli. Tsuji H; Ohashi Y; Okumura K; Tsuji A; Muto Y; Goto S Chemotherapy; 1982; 28(1):26-39. PubMed ID: 7035089 [TBL] [Abstract][Full Text] [Related]
17. Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases. Sougakoff W; Jarlier V J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():9-14; discussion 63-5. PubMed ID: 11051618 [TBL] [Abstract][Full Text] [Related]
18. Effective antimicrobial activity of Cbf-K16 and Cbf-A7 A13 against NDM-1-carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro. Hao Q; Wang H; Wang J; Dou J; Zhang M; Zhou W; Zhou C J Pept Sci; 2013 Mar; 19(3):173-80. PubMed ID: 23389882 [TBL] [Abstract][Full Text] [Related]
19. Penetration through the gram-negative cell wall: a co-determinant of the efficacy of beta-lactam antibiotics. Zimmermann W Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):131-4. PubMed ID: 107128 [TBL] [Abstract][Full Text] [Related]
20. Outer membrane permeability of imipenem in comparison with other beta-lactam antibiotics. Hashizume T; Yamaguchi A; Sawai T J Antibiot (Tokyo); 1986 Jan; 39(1):153-6. PubMed ID: 3512504 [No Abstract] [Full Text] [Related] [Next] [New Search]